Do you or don’t you?
Odds are, you do. Latest studies show that a majority of cancer patients use some form of CAM, or complementary medicine. Increasingly, alternative treatments are now being seen as integrative, and are integrated with traditional, or allopathic medical care. For example, yoga or a vegetarian diet might be integrated with chemotherapy.
More studies are being done demonstrating the value of good nutrition combined with physical exercise/movement and stress reduction (yoga, meditation, etc.). The site contains articles on everything – from the tried and true (take Vitamin D to improve bone health) to the not-so-accepted, like uropathy (drinking one’s own urine).
For more information, check out:
A nonprofit corporation that provides information, education, advocacy and awareness for people with cancer, family and friends interested in complementary and alternative medicine (CAM) and natural therapies from the patient perspective.
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...